The gonococcal chromosome contains a sequence of closely linked genes (for example, sac-1, sac-3, nmp) known or presumed to affect cell envelope structure and which appear to influence susceptibility of gonococci to killing by normal human sera (NHS). Previous work has shown that the serum-resistant isolate FA19, and FA899, a serum-sensitive transformant of FA19, differ in outer membrane protein I (PI) and at the sac-3 genetic locus. However, the sac-3 locus is separable from changes determined by nmp-3, the gene determining PI species. We found that FA1 9 and FA899 differ in lipopolysaccharide (LPS) molecular size and in reactivity with a monoclonal antibody which recognizes an LPS (L8) epitope. To address the question of whether the changes in LPS were due to the sac-3 locus, we constructed new transformants of FA19 using donor DNA prepared from FA899. The new transformants could be divided into three groups : (1) those identical to FA19 in serum resistance (> 90% survival at 120 min), in LPS molecular size and in expression of the L8 epitope; (2) those identical to FA899 in serum sensitivity (100% killed at 30 min), in LPS molecular size and in lack of expression of the L8 epitope; (3) those significantly killed by 50% NHS at 120 min, whose LPS molecular size was greater than that of FA19 but less than that of FA899 and which did not express the L8 epitope. Except for PI there were no differences in other outer-membrane proteins (e.g. PII, PIII, H.8) among these transformants. Studies of PI using monoclonal antibodies which distinguish between PI serovars confirmed that changes in PI were separate from changes in serum resistance or alteration in LPS chemotype. These data indicate that a genetic locus involved in LPS structure appears to be identical with the sac-3 locus, which influences serum susceptibility in Neisseria gonorrhoeae.
INTRODUCTION
Gonococci isolated from patients with disseminated gonococcal infections are typically resistant to complement-mediated killing by normal human serum (NHS) (Schoolnik et al., 1976) . In contrast, strains isolated from patients with uncomplicated gonococcal infections tend to be sensitive to NHS (Brooks & Ingwer, 1978) . The molecular basis of serum resistance of gonococci remains unknown. Nevertheless, at least two closely linked genes termed sac-I and sac-3 (sac: serum antibody complement) have been described (Cannon et al., 1981 ; Shafer et al., 1982) . Expression of these loci has been suggested to result in the alteration of the gonococcal cell envelope providing for serum resistance (Sac').
Gene products of sac-I and sac-3 providing for Sac' have not been described. Genetic studies (Cannon et al., 1981; Shafer et al., 1982) have separated sac-1 and sac-3 from nrnp (new membraneprotein) loci involved in PI synthesis; alterations in PI had earlier been thought to be responsible for Sac ' (Hildebrandt et al., 1978) . Changes in lipopolysaccharide (LPS) structure levels. Isolates to be tested were grown on GCISO agar plates [GC agar base (BBL) plus 2% (v/v) IsovitaleX] (Stephens & McGee, 1983 ) for 14-16 h at 37 "C in 3% (v/v) COz. Inocula (Op-, Pil-) were prepared, diluted to the desired concentration and used immediately in the SBA. In some experiments hypogammaglobulinaemic serum from a patient with acquired common variable immunodeficiency or C2-deficient human serum (Cytotech) were used. Serum (0.5 ml), bacterial inoculum (0.1 ml) and HEPES-MEM (0.4 ml) were mixed so that the final suspension contained 1 ml with 50% (v/v) serum and 2 x lo4 c.f.u. ml-I. The reaction mixture was incubated at 37 "C in 3% (v/v) COz with end-over-end rotation. Triplicate samples (0.01 ml) were withdrawn from the reaction mixture immediately after preparation and after 15, 30, 60 and 120 min incubation. Colony counts were performed as previously described (Stephens & McGee, 1983) . After overnight incubation of the plates, the number of c.f.u. per sample was counted and the number of c.f.u. ml-1 in the original mixture at each sampling time was calculated. Data were expressed as percentage survival. The significance of differences between the means of two variables was determined using Student's t-test with unpaired values and a two-tailed hypothesis.
Genetic transformation. Transforming DNA used in these experiments was prepared by the method of Marmur (1961). Transforming DNA was prepared from strain FA899 (sac-3+) and used to transform strain FA19 (sac-3) by techniques described previously (Shafer et af., 1981) . Limiting concentrations (0.1 pg m1-I) of DNA were used. Spectinomycin resistant (Spc') transformants were selected using GC base agar overlays containing 100 pg spectinomycin ml-' (Shafer et al., 1982) .
Biochemical and immunochemical analysis of gonococcal strains. SDS-PAGE of lysates of whole gonococci was done using 15% (w/v) acrylamide gels by techniques previously described (Stephens et a/., 1985) . Proteinase K digests of the whole cell lysates were prepared (Hitchcock & Brown, 1983 ) and the gels were silver stained (Tsai & Frasch, 1982) .
Western immunoblotting was done by a modification of the method of Towbin et al. (1979) as previously described (Stephens et al., 1985) . Monoclonal antibody L8, an IgG class immunoglobulin (kindly supplied by Dr Wendell Zollinger, Walter Reed Army Institute of Research) was used in these experiments. L8 recognizes a Neisseria LPS epitope (designated L8) associated with Sac' but not SacS gonococcal strains (Schneider et af., 1985) . Antibody binding to LPS immobilized on nitrocellulose was detected using staphylococcal protein A conjugated with peroxidase as previously described (Stephens et af., 1985) .
RESULTS
Strain FA19 resists killing by 50% (v/v) NHS over a 120 min incubation while FA899 is rapidly killed by NHS (Fig. 1) . These strains differ in PI molecular mass (Shafer et al., 1982) . The results of PI serovar typing ( 4 Sac', resistant to killing by 50% NHS; Sac', sensitive to killing by 50% NHS at -= 30 min; Sacs*, sensitive to killing by 50% NHS at 120min. and Sacs* transformants. The molecular size of the LPS was calculated in separate experiments using low-molecular-weight protein standards (BRL) and Re, Rd and smooth Salmonella minnesota mutants.
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(b) Western immunoblot of the electrophoresed lysates in (a), probed with Mab L8. The Sac' transformants SS-13 and SS-14, and FA19, express the L8 LPS epitope while the Sacs* transformants SS-9 and SS-12 and the SacS strain FA899 do not. Similar results were seen with the other Sac' and Sacs* transformants.
Differences in LPS have not been previously noted between these strains (Shafer et al., 1982) . However, as shown in Fig. 2(a) we found, using techniques developed for examination of LPS by SDS-PAGE (Hitchcock 8z Brown, 1983) , that FA19 and FA899 differed in LPS molecular size. FA19 and FA899 also differ in the capacity of Mab L8 to recognize their respective LPS in Western immunoblots (Fig. 2 b and Table 1 ). This result suggested that the presence of a genetic determinant closely linked or identical to sac-3 is involved in the synthesis of LPS from Sacr strain FA19.
#
In order to substantiate the presence of an LPS biosynthetic gene in the sac-3+ region, DNA was prepared from strain FA899 and used to transform strain FA19. Spcr transformants were selected since suc-3+ cotransforms with spc-4 (Shafer et al., 1982) . Fourteen Spcr transformants (SS 1-14) of FA19 were studied for changes in serum susceptibility, LPS molecular size, reactivity with Mab L8, outer-membrane proteins, and PI serovar. As shown in Table 1 and Fig.   1 , Sacr ( > 90% survival at 120 min), SacS (100% killed at 30 min) and Sacs* ( > 90% killed at 120 min) transformants were obtained. Inocula of the parental Sacr strain FA19 and the Sacr transformants exhibited some killing (< 50% of inoculum) at 30 rnin in 50% (v/v) NHS. However, by 120 min multiplication of these strains was occurring, with colony counts occasionally increasing to > 100% of the initial inoculum. The SacS transformant SS-2, like the donor strain FA899, was rapidly killed. Data from earlier time points (not shown) indicated that killing of these strains was rapid, within 15 rnin of beginning the experiment. Other transformants (e.g. SS-9) displayed intermediate susceptibility to 50 % NHS (Sacs*). Killing of Sacs* transformants occurred in a delayed fashion over a period of 120min (Fig. 1) . 
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CZdeficient serum (0), and gonococcal strain SS-9 (Sacs*). SS-9 is significantly killed by NHS at 120 min but is resistant to killing by the other two sera. Data are expressed as the means f SEM of three or more experiments with each variable.
All Sacr transformants exhibited an LPS molecular size (-5.8 kDa) and L8 reactivity profile like [hat of FA19 (Table 1, Fig. 2) . The SacS transformant (SS-2) had an LPS molecular size (-6.6 kDa) identical to the donor strain FA899 and failed to react with the L8 Mab (Table 1, Fig. 3 ). The molecular size (-6-2 kDa) of LPS from the transformants of intermediate serum sensitivity (SacS*) was distinct from that of FA19 and FA899 (Fig. 2a) . LPS from Sacs* transformants failed to react with L8 Mab (Fig. 2b) .
All SacS and Sacs* transformants retained the PI serovar (1 B9) of the donor, yet serovar 1 B9 transformants (3/8) were recovered from transformants which remained Sacr and reacted with Mab L8 in Western blots (Table 1) . The remaining Sacr transformants were PI serovar IA1. Except for PI no differences in other outer-membrane proteins (e.g. PII, PIII) were noted by SDS-PAGE. The molecular mass of antigen H.8 of FA19, FA899 and transformants SS-1 to SS-14 was also identical as determined in Western immunoblots by monoclonal antibody (kindly supplied by Dr J. Cannon, University of North Carolina).
In order to investigate the mechanism of killing of the intermediate transformants (antibodydependent or -independent, alternative or classical activation of complement) hypogammaglobulinaemic human serum and CZdeficient human serum were used (Fig. 4) . The Sacs* transformant SS-9 was resistant to killing by both these sera at 120 min, in contrast to significant killing in NHS at 120min. This suggests that the killing of strain SS-9 is by an antibodydependent, classical pathway.
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In this study we show that a genetic determinant involved in LPS structure appears to be sac-3. This area of the gonococcal chromosome in Sacr strain FA19 has been previously associated with the synthesis of cell envelope structures thought to contribute to the Sac' phenotype (Cannon et al., 1981 ; Shafer et al., 1982) . The well-described sac-l locus (Cannon et  al., 1981) , which also gives a Sacr phenotype, is in this region. We were able to separate expression of sac-l from sac-3 by using high concentrations of NHS (Shafer et al., 1982) and by noting in the current study that in isogenic strains differing at sac-1+, reactivity with Mab L8 was identical (data not shown). Our studies represent the first delineation of a locus (sac-3) involved in LPS structure in this region of the gonococcal chromosome.
This work substantiates earlier observations that sac-3 and nmp-3 are linked but not identical, thus indicating that changes in PI do not always result in changes in susceptibility to NHS. Less clear, however, is whether acquisition of sac-3 results in presentation of an LPS epitope defined by Mab L8. Although we were unable to dissociate these phenotypes, the sac-3 locus and a distinct LPS gene determining L8 reactivity may be closely linked, requiring examination of additional transformants in order to identify recombinants which express only one phenotype. This is particularly important because transformants were obtained which displayed killing by NHS in a delayed fashion. Although such transformants lacked reactivity with Mab L8, they appeared to synthesize an LPS with a molecular size intermediate to that of the parent and donor strains. The molecular basis for this type of recombinant, termed Sacs*, is unknown. It may be indicative of two closely linked loci in sac-3+ strains which provide for distinct levels of susceptibility to NHS. It is important to clarify this issue because in the serum-sensitive transformants (Sacs, Sacs*) only one transformant, SS-2, displayed the same phenotypic profile as the donor strain FA899. We are currently examining the possibility that a second gene is responsible for the Sacs* phenotype.
It was not surprising that alterations in LPS structure were associated with changes in susceptibility of gonococci to human sera. In Salmonella species, deep rough mutants containing truncated LPS are more serum sensitive than the isogenic smooth parental strains (Muschel8z Larsen, 1980) . Similarly, studies of serum-sensitive gonococcal mutants, selected by pyocins, have associated loss of components of LPS core polysaccharides to increased susceptibility to NHS (Guymon et al., 1982; Morse & Apicella, 1982; Shafer et al., 1984) . However, in our study a decrease in LPS molecular size was associated with increasing serum resistance. Recently serum resistance in N . gonorrhoeae was shown to be related to the lack of a high molecular mass LPS moiety (Tan et al., 1986) . In addition, resistance of certain strains of N . gonorrhoeae to the bacteriolytic action of NHS has been shown to result from the absence from their LPS of antigenic loci for the lytic immunoglobulin M that is present in most NHS (Schneider et al., 1982) . Taken together these data suggest that a mechanism of serum resistance in N . gonorrhoeae may be the loss of LPS epitope(s) recognized by naturally occurring bactericidal anti body.
Using isogenic strains, we confirm and extend this hypothesis. We found that expression of a specific LPS epitope (possibly through loss of components that previously masked this epitope) is related to serum resistance. The L8 LPS epitope has been defined (Schneider et al., 1984 (Schneider et al., ,1985 to be within a -3.6 kDa component of gonococcal and meningococcal LPS, and to be commonly expressed by Sacr strains of N . gonorrhoeae. In a study of 40 randomly selected normal young adults none had evidence of antibody to this epitope (Schneider et al., 1985) . We found that the L8 epitope was expressed by the serum-resistant strain FA19 and by all the Sac' transformants, but not by SacS strains.
The lack of expression of the L8 epitope and the intermediate size of LPS in our Sacs* transformants, which exhibit delayed killing to 50% NHS, supports the concept that several alterations in LPS, leading to expression of L8, relate to the ability of gonococci to resist killing by human sera. It is likely that multiple genes are involved in synthesis of gonococcal LPS. The sac-3 locus may code for an enzyme which modifies LPS structure in such a way as to expose the L8 epitope. In order to identify further the mechanism by which sac-3 affects LPS, isolation and sequencing of the gene are required. In addition, studies using a panel of LPS monoclonal 
